Short Summary
3Shape and Medit have filed a joint motion asking the PTAB to keep their settlement agreement confidential under patent‑law confidentiality provisions.
Detailed Summary
In IPR2024-01268, 3Shape A/S and 3Shape Inc. petition the Patent Trial and Appeal Board to treat their settlement agreement with Medit Corporation as business confidential information. Citing 35 U.S.C. §317 and 37 C.F.R. §42.74, the petitioners request that the agreement be kept separate from the patent file and disclosed only upon a showing of good cause. The motion aims to protect the settlement terms from public disclosure while the underlying IPR proceeds.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in 3Shape A/S et al. vs Medit Corporation et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Inari Agriculture, Inc.vsPioneer Hi-Bred International, Inc.
Inari Agriculture challenges the PTAB’s denial of its PGR, arguing the Board improperly required seed sequencing under §103 for a plant utility patent. The petition seeks director review to overturn the denial and restore the ability to contest the patent without analyzing deposited seed.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck has filed a post‑grant review petition challenging Halozyme’s enzyme patent, arguing the claims lack adequate written description and enablement. The reply emphasizes functional language and the impossibility of testing the claimed 1,059+ PH20 variants.
Activision Blizzard, Inc.vsMilestone Entertainment, LLC
Activision Blizzard’s IPR petition targeting Milestone Entertainment’s virtual‑currency gaming patent was rejected. The patent owner showed the prior art fails to disclose key claim elements and that no motivation to combine existed.
Taiwan Semiconductor Manufacturing Company, Ltd. et al.vsMarlin Semiconductor Ltd. et al.
TSMC seeks Director review of a denied institution decision, arguing that the ’747 patent was erroneously issued and threatens U.S. national‑security‑critical chip production. The petition highlights material examiner errors, lack of settled expectations by the patent owner, and the impact of the 2025 government shutdown on the Fintiv analysis.
Microsoft Corp.vsVirtaMove, Corp.
Microsoft has filed an IPR petition seeking cancellation of nine claims of VirtaMove’s ’814 patent, arguing the claims are obvious over earlier container‑virtualization technologies such as Linux VServer, Solaris Zones, and Zap pods.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.